EIF3J

Eukaryotic translation initiation factor 3 subunit J · O75822 · EIF3J on Sugi Atlas →

0 patent compounds predicted against EIF3J, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EIF3J by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer PHASE1/PHASE2COMPLETED
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer PHASE2ACTIVE_NOT_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer PHASE1COMPLETED
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Quantification of GADD34 Expression in RA nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique nanCOMPLETED
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Molecular Phenotype Changes and Personalized Treatment for CRPC nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a EIF3J binder may also engage these)

ProteinNameSimilarity
Q5R8D1 1.000 Q5R8D1 →
A0JPM9 1.000 A0JPM9 →
Q66JS6 1.000 Q66JS6 →
Q0VCU8 1.000 Q0VCU8 →
Q3UGC7 1.000 Q3UGC7 →
Q5ZKA4 0.997 Q5ZKA4 →
SAP30BP SAP30-binding protein 0.969 landscape →
Q7TNE3 0.968 Q7TNE3 →
O75391 0.967 O75391 →
Q5ZJ85 0.964 Q5ZJ85 →
Q96MW1 0.963 Q96MW1 →
Q7SXU0 0.963 Q7SXU0 →
Q9Z1M8 0.962 Q9Z1M8 →
Q5NVI3 0.962 Q5NVI3 →
P29540 0.961 P29540 →
Q5RAD5 0.961 Q5RAD5 →
Q922U1 0.960 Q922U1 →
Q02614 0.960 Q02614 →
PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 0.960 landscape →
CLTA Clathrin light chain A 0.960 landscape →
Q5I0B5 0.958 Q5I0B5 →
A2AQ19 0.958 A2AQ19 →
Q5R5F1 0.958 Q5R5F1 →
Q2KIA6 0.957 Q2KIA6 →
Q6INR1 0.957 Q6INR1 →
Q2KJF9 0.957 Q2KJF9 →
RTF1 RNA polymerase-associated protein RTF1 homolog 0.957 landscape →
Q2HJ41 0.956 Q2HJ41 →
IK Protein Red 0.956 landscape →
Q91WE2 0.955 Q91WE2 →